Maher Albitar, Chief Medical Officer at NEOGENOMICS INC (NEO), bought 14,492 shares at $3.51 ($51K) on 2014-03-28, disclosed to the SEC on 2014-03-31.
Open-market purchase of $51k NEO by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| NEO | SELL | 2016-09-13 | $988K | — | Filing → |
| NEO | SELL | 2016-08-23 | $3.0M | — | Filing → |